We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

High Throughput Screening – Accelerating drug discovery efforts

Article   May 26, 2017 | By Jack Rudd, Senior Editor at Technology Networks

 
High Throughput Screening – Accelerating drug discovery efforts

Jack Rudd

Managing Editor

 
 
 

RELATED ARTICLES

The First Winners of the LEA

Article

The Lipidomics Excellence Award (LEA) was founded to strengthen life sciences through lipidomics. After reviewing the many high-quality submitted projects, the LEA jury has announced the three awardees.

READ MORE

Antibodies in Research: The Good, the Bad, and the Validation Epidemic

Article

The specificity of antibody binding is incredibly important for many research disciplines, yet sourcing the best antibody for your research can be a challenge. This is partly because not all suppliers validate their antibodies sufficiently. How much of a problem is this?

READ MORE

Why Does Ketamine Fight Depression? Finding Answers at BNA 2019

Article

A significant minority of major depressive disorder patients don’t respond to currently available antidepressant medication. A newly approved treatment, based on the "club drug" ketamine, could change that. In a session at the British Neuroscience Association’s Festival of Neuroscience 2019, the potential mechanisms of ketamine’s antidepressant action were put under examination.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE